Global Anti Rheumatic Trends in 2022
Anti Rheumatic is part of Therapy. You may also be interested in Anesthetics, Anti-Infective and Cardiovascular Drug.
Global sales of antirheumatic medicines are forecast to reach $2.6 billion by 2026, down 1.5% annually from $2.9 billion in 2021. Since 2017, the market has dropped an average of 0.3% each year. In 2021, South Korea led the way in antirheumatic medicine sales with $677 million. Germany, Spain and Canada were second, third and fourth, respectively. The Czech Republic saw annual growth of 5.6%, while Ireland experienced a 9% drop since 2017.
Top 10 countries
In 2022 major markets in the Anti Rheumatic Industry were:
Anti Rheumatic Market Data and Forecasts
How much the Anti Rheumatic industry is expected to grow to 2026?
More in Anti Rheumatic Industry for 2028Global Anti Rheumatic Statistics
- Organic Chemicals Import 191 countries (Asia, Africa, Latin America...)
- Antirheumatic Medicine Sales 42 countries (Europe, Northern Europe, Southern Europe...)
- Organic Chemicals Export 181 countries (Asia, Latin America, Europe...)
- Herbicide Sales 57 countries (Europe, Southern Europe, Western Europe...)